Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitisMei Yang, Dong‐Qing Ye, Faming Pan et al.|Clinical Rheumatology|2010Cited by 230
Analysis on the interaction between IL-1F7 gene and environmental factors on patients with ankylosing spondylitis: a case-only studyRui Ge, Jianhua Xu, Faming Pan et al.|Molecular Biology Reports|2010Cited by 19
Association of FCRL4 polymorphisms on disease susceptibility and severity of ankylosing spondylitis in Chinese Han populationZhen Zeng, Faming Pan, Zhenhua Duan et al.|Clinical Rheumatology|2012Cited by 17
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Xiaofeng Zeng, Lei Yang et al.|Annals of the Rheumatic Diseases|2025Cited by 17